Cargando…
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
The tumour immune microenvironment is considered to influence cancer behaviour and outcome. Using a panel of markers for innate and adaptive immune cells we set out to characterise and understand the bladder tumour microenvironment of 114 patients from a prospective multicentre cohort of newly-diagn...
Autores principales: | Dowell, Alexander C., Cobby, Ellen, Wen, Kaisheng, Devall, Adam J., During, Vinnie, Anderson, Jane, James, Nicholas D., Cheng, Kar K., Zeegers, Maurice P., Bryan, Richard T., Taylor, Graham S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607173/ https://www.ncbi.nlm.nih.gov/pubmed/28931051 http://dx.doi.org/10.1371/journal.pone.0184841 |
Ejemplares similares
-
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014) -
Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial
por: Bryan, Richard T., et al.
Publicado: (2023) -
The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019) -
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation
por: Russo, Ilaria J., et al.
Publicado: (2018) -
Mast Cells and Interleukins
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)